MetaLabs (Korea) Performance
| 090370 Stock | 1,362 6.00 0.44% |
MetaLabs has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.62, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MetaLabs' returns are expected to increase less than the market. However, during the bear market, the loss of holding MetaLabs is expected to be smaller as well. MetaLabs right now secures a risk of 2.33%. Please verify MetaLabs Co total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if MetaLabs Co will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in MetaLabs Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, MetaLabs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 3.3 B | |
| Total Cashflows From Investing Activities | -20.7 B |
MetaLabs |
MetaLabs Relative Risk vs. Return Landscape
If you would invest 134,300 in MetaLabs Co on November 28, 2024 and sell it today you would earn a total of 1,300 from holding MetaLabs Co or generate 0.97% return on investment over 90 days. MetaLabs Co is generating 0.0436% of daily returns and assumes 2.3288% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than MetaLabs, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MetaLabs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetaLabs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MetaLabs Co, and traders can use it to determine the average amount a MetaLabs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0187
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 090370 |
Estimated Market Risk
| 2.33 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average MetaLabs is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MetaLabs by adding it to a well-diversified portfolio.
MetaLabs Fundamentals Growth
MetaLabs Stock prices reflect investors' perceptions of the future prospects and financial health of MetaLabs, and MetaLabs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MetaLabs Stock performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.0071 | |||
| Profit Margin | (0.59) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | (25.55 B) | |||
| Shares Outstanding | 4.98 M | |||
| Price To Book | 0.19 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 39.3 B | |||
| EBITDA | (12.25 B) | |||
| Cash Flow From Operations | 2.28 B | |||
| Total Asset | 85.03 B | |||
About MetaLabs Performance
By analyzing MetaLabs' fundamental ratios, stakeholders can gain valuable insights into MetaLabs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MetaLabs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MetaLabs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about MetaLabs performance evaluation
Checking the ongoing alerts about MetaLabs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MetaLabs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 39.3 B. Net Loss for the year was (14.51 B) with profit before overhead, payroll, taxes, and interest of 20.13 B. | |
| About 56.0% of the company shares are owned by insiders or employees |
- Analyzing MetaLabs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MetaLabs' stock is overvalued or undervalued compared to its peers.
- Examining MetaLabs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MetaLabs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MetaLabs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MetaLabs' stock. These opinions can provide insight into MetaLabs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MetaLabs Stock analysis
When running MetaLabs' price analysis, check to measure MetaLabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaLabs is operating at the current time. Most of MetaLabs' value examination focuses on studying past and present price action to predict the probability of MetaLabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaLabs' price. Additionally, you may evaluate how the addition of MetaLabs to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |